RecruitingNot Applicable

Electrophysiological Registry Duesseldorf

Germany1,000 participantsStarted 2019-06-01

Plain-language summary

This registry at University Hospital Düsseldorf collects retrospective and prospective (from 2019 onward) data on patients undergoing electrophysiological studies (EPS), catheter ablation, and electrical cardioversion. The primary goal is to evaluate safety, efficacy, and clinical outcomes of these standard procedures in routine care. Data will be used for quality assurance and to identify prognostic patient- and procedure-related factors.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who undergo an electrophysiological study (EPS) or electrical cardioversion at University Hospital Düsseldorf since 2015 (retrospective cohort) * Patients scheduled to undergo an EPS or electrical cardioversion at University Hospital Düsseldorf from 2019 onward (prospective cohort) •- Written informed consent for participation in the registry (prospective part only) Exclusion Criteria: * \< 18 years * Lack of written informed consent * Pregnancy

What they're measuring

Periprocedural and postprocedural safety events

Timeframe: Up to 24 months after procedure

Clinical efficacy outcomes

Timeframe: Up to 24 months after procedure

Trial details

NCT IDNCT07196176

SponsorHeinrich-Heine University, Duesseldorf

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-12-31

Contact for this trial

Obaida Rana, MD

+492118118800 obaida.rana@med.uni-duesseldorf.de

View on ClinicalTrials.gov More Atrial Fibrillation (AF) trials